High expression of ABCF1 is an independent predictor of poor prognosis in bladder cancer

被引：0
作者：
JiaWen Fan
Yi Ding
HaoXuan Huang
ShiDa Xiong
Liang He
Ju Guo
机构：
[1] The First Affiliated Hospital of Nanchang University,Department of Urology
[2] The Second Affiliated Hospital of Jiujiang University,undefined
来源：
BMC Urology | / 23卷
关键词：
Bladder cancer; ABCF1; GSEA; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
ABCF1, a member of the ATP-binding cassette (ABC) transporter family, is involved in the malignant progression of tumors. However, the role of ABCF1 in bladder cancer is poorly understood. In our study, we explored the differential expression of ABCF1 in bladder cancer and normal bladder tissues based on bioinformatic analysis and immunohistochemical results. GSEA was performed to ascertain the potential related signaling pathways of ABCF1. The relationship between ABCF1 expression and bladder cancer progression was analyzed using the GSE13507 dataset. In addition, the differential expression of ABCF1 in the cell lines was verified by quantitative real-time polymerase chain reaction (qRT‒PCR) and Western blotting. ABCF1 was upregulated in bladder cancer, and the high expression of ABCF1 was closely related to sex (P = 0.00056), grade (P = 0.00049), T stage (P = 0.00007), and N stage (P = 0.0076). High expression of ABCF1 was correlated with poor overall survival in bladder cancer patients (P < 0.001). In addition, univariate and multivariate Cox regression analyses showed that high ABCF1 expression was an independent factor for poor prognosis in bladder cancer patients. Therefore, ABCF1 expression is closely related to the progression of bladder cancer and can be used as a potential indicator of poor prognosis and a therapeutic target for bladder cancer.
引用
收藏
相关论文
共 244 条
  • [1] Sung H(2021)Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Ca-a Cancer J Clin 71 209-249
  • [2] Ferlay J(2017)Bladder cancer incidence and mortality: a global overview and recent trends Eur Urol 71 96-108
  • [3] Siegel RL(2020)An EMT-related gene signature for the prognosis of human bladder cancer J Cell Mol Med 24 605-617
  • [4] Laversanne M(2021)Advances in bladder cancer biology and therapy Nat Rev Cancer 21 104-121
  • [5] Soerjomataram I(2018)The evolution of bladder cancer genomics: what have we learned and how can we use it? Urologic Oncol Semin Original Invest 36 313-320
  • [6] Jemal A(2017)The evolving genomic landscape of urothelial carcinoma Nat Rev Urol 14 215-229
  • [7] Bray F(2012)Progress in personalizing chemotherapy for bladder cancer Adv Urol 2012 364919-364919
  • [8] Antoni S(2009)Human ATP-binding cassette (ABC) transporter family Hum Genom 3 281-290
  • [9] Ferlay J(2015)The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade Drug Resist Updates 18 1-17
  • [10] Soerjomataram I(2014)ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit Can Res 74 4196-4207
12345678910